Tryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer’s disease? - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Progress in Neurobiology Année : 2020

Tryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer’s disease?

Résumé

Among several processes, a decrease in amyloid-beta (Aβ) peptide elimination is thought to be one of the major pathophysiological factors in Alzheimer’s disease (AD). Neprilysin (NEP) is a key metalloproteinase controlling the degradation and clearance of Aβ peptides in the brain. NEP is induced by several pharmacological substances, amyloid deposits and somatostatin, but the physiological regulation of its expression remains unclear. This situation hampers the exploitation of NEP regulatory factors/mechanisms to develop effective strategies against Aβ peptide accumulation-induced brain toxicity. Based on recent data aimed at elucidating this major question, the present paper addresses and critically discusses the role of 5-hydroxyindole-acetic acid (5-HIAA) and kynurenic acid (KYNA) in the regulation of NEP activity/expression in the brain. Both 5-HIAA and KYNA are endogenous metabolites of tryptophan, an essential amino-acid obtained through diet and gut microbiome. By interacting with the aryl hydrocarbon receptor, various tryptophan metabolites modulate several metalloproteinases regulating brain Aβ peptide levels under normal and pathological conditions such as AD. In particular, interesting data reviewed here show that 5-HIAA and KYNA stimulate NEP activity/expression to prevent Aβ peptide-induced neurotoxicity. These data open promising perspectives for the development of tryptophan metabolite-based therapies against AD.
Fichier principal
Vignette du fichier
islandora_94567.pdf (1.2 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02620451 , version 1 (25-05-2020)

Identifiants

Citer

Michel Maitre, Christian Klein, Christine Mensah-Nyagan, Ayikoe-Guy Mensah-Nyagan. Tryptophan metabolites modify brain Aβ peptide degradation: A role in Alzheimer’s disease?. Progress in Neurobiology, In press, ⟨10.1016/j.pneurobio.2020.101800⟩. ⟨hal-02620451⟩

Collections

INSERM SITE-ALSACE
38 Consultations
688 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More